PCG
Prosperity Consulting Group’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
3,283
-3,678
| -53% | -$254K | 0.02% | 418 |
|
|
2025
Q1 | $483K | Sell |
6,961
-1,726
| -20% | -$120K | 0.04% | 305 |
|
|
2024
Q4 | $747K | Sell |
8,687
-3,107
| -26% | -$267K | 0.06% | 263 |
|
|
2024
Q3 | $1.4M | Buy |
11,794
+8,440
| +252% | +$1M | 0.11% | 185 |
|
|
2024
Q2 | $479K | Sell |
3,354
-38
| -1% | -$5.42K | 0.06% | 197 |
|
|
2024
Q1 | $436K | Buy |
+3,392
| New | +$436K | 0.05% | 224 |
|